CHRU de Nantes

Nantes 44000

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia (AML), Acute Myocardial Infarction, Diffuse Large B Cell Lymphoma (DLBCL), Relapsed or Refractory Multiple Myeloma (RRMM)

Studies at this site

• GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies — Stopped early
• Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) — Completed